TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid under hypoxic condition after 16 to 24 hrs by luciferase ...More data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 40nMAssay Description:Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid under hypoxic condition after 16 to 24 hrs by luciferase ...More data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 71nMAssay Description:Inhibition of hypoxia-induced HIF1 activation in human U251 cellsMore data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 120nMAssay Description:Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid under hypoxic condition after 16 to 24 hrs by luciferase ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 130nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 170nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 400nMAssay Description:Inhibition of hypoxia-induced HIF1 activation in human T47D cells carrying pTK-HER3-luc reporter gene measured by luciferase activityMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 500nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 530nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 560nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 600nMAssay Description:Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid under hypoxic condition after 16 to 24 hrs by luciferase ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 600nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 600nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 760nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 780nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 800nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 820nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 830nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 980nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.02E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.12E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.12E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.19E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.20E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.20E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.40E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.49E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.51E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.60E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.63E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.63E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.70E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.71E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.80E+3nMAssay Description:NIH3T3-EPO-luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.85E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.86E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.88E+3nMAssay Description:Activation of human HIF1alpha expressed in human U2OS cells assessed as increase in VEGF expression by RT-PCR analysisMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.90E+3nMAssay Description:HaCaT-EPO-Luc cells were maintained at 37° C. in a humidified atmosphere containing 5% CO2 in DMEM supplemented with 10% fetal calf serum (FBS), and ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.97E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetEndothelial PAS domain-containing protein 1/Hypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Saic-Frederick
Curated by ChEMBL
Saic-Frederick
Curated by ChEMBL
Affinity DataEC50: 2.00E+3nMAssay Description:Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid under hypoxic condition after 16 to 24 hrs by luciferase ...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.06E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.11E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.25E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.26E+3nMAssay Description:The activities of compounds of the invention in inducing erythropoietin (EPO) production were assessed by using human live cancer cell strain Hep3B (...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.28E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.29E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.30E+3nMAssay Description:Activation of GFP-tagged HIF1alpha expressed in human U2OS cells assessed as HIF1alpha nuclear translocation by high content imaging assayMore data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.33E+3nMAssay Description:Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubat...More data for this Ligand-Target Pair